VX-440

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Cystic Fibrosis

Phase 1

A Study Evaluating Safety and Pharmacokinetics of VX-440 in Combination With Tezacaftor/Ivacaftor in Healthy Adult Subjects

CompletedNCT03486236

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2016-07-20End: 2016-09-14Updated: 2018-04-03

Phase 2

A Study Evaluating the Safety and Efficacy of VX-440 Combination Therapy in Subjects With Cystic Fibrosis

CompletedNCT02951182

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2016-10-31End: 2017-08-31Updated: 2020-08-28